We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-8.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$74.3B
AUM Growth
-$8.62B
(-10%)
Cap. Flow
-$532M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
784
New
89
Increased
180
Reduced
401
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$556M |
| 2 |
NVIDIA
NVDA
|
+$117M |
| 3 |
Oracle
ORCL
|
+$104M |
| 4 |
Amazon
AMZN
|
+$79.8M |
| 5 |
Expedia Group
EXPE
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$161M |
| 2 |
Parker-Hannifin
PH
|
+$138M |
| 3 |
Cummins
CMI
|
+$94.8M |
| 4 |
Mettler-Toledo International
MTD
|
+$82.8M |
| 5 |
Home Depot
HD
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.44% |
| 2 | Communication Services | 20.45% |
| 3 | Consumer Discretionary | 17.53% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Simon Property Group
SPG
$74.7B
| $7.01M | 0.01% |
37,607
-9,220
| -20% | -$1.76M |
|
377
Encompass Health
EHC
$11B
| $7.01M | 0.01% |
+72,488
| New | +$7.43M |
|
378
US Bancorp
USB
$98B
| $6.93M | 0.01% |
133,179
-9,511
| -7% | -$523K |
|
379
iShares Russell 1000 Value ETF
IWD
$81.8B
| $6.72M | 0.01% |
31,469
| – | – |
|
|
OPTU
380
Optimum Communications Inc
OPTU
$290M
| $6.61M | 0.01% |
5,084,853
| – | – |
|
381
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
| $6.53M | 0.01% |
154,258
-311,742
| -67% | -$13.3M |
|
382
PNC Financial Services
PNC
$99.2B
| $6.49M | 0.01% |
31,205
+8,380
| +37% | +$1.82M |
|
383
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $6.49M | 0.01% |
81,550
+5,550
| +7% | +$446K |
|
384
Gilead Sciences
GILD
$163B
| $6.42M | 0.01% |
46,065
-15,424
| -25% | -$2.16M |
|
|
GRMN
385
Garmin
GRMN
$57.4B
| $6.04M | 0.01% |
26,045
+4,435
| +21% | +$993K |
|
386
Procter & Gamble
PG
$335B
| $5.91M | 0.01% |
40,929
-23,180
| -36% | -$3.51M |
|
387
AbbVie
ABBV
$455B
| $5.79M | 0.01% |
26,603
-1,535
| -5% | -$341K |
|
388
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.37B
| $5.69M | 0.01% |
112,759
-59,241
| -34% | -$3M |
|
389
Vanguard Total Corporate Bond ETF
VTC
$1.72B
| $5.6M | 0.01% |
72,888
+4,888
| +7% | +$379K |
|
390
Kinross Gold
KGC
$28B
| $5.5M | 0.01% |
180,232
+127,378
| +241% | +$4.17M |
|
391
Kimberly-Clark
KMB
$36.6B
| $5.4M | 0.01% |
55,970
-45,508
| -45% | -$4.66M |
|
392
Citigroup
C
$222B
| $5.31M | 0.01% |
46,802
+16,149
| +53% | +$1.84M |
|
393
ASML
ASML
$634B
| $5.24M | 0.01% |
3,969
-2,769
| -41% | -$3.79M |
|
394
Emerson Electric
EMR
$83.3B
| $5.19M | 0.01% |
39,599
-11,760
| -23% | -$1.69M |
|
|
EFT
395
Eaton Vance Floating-Rate Income Trust
EFT
$283M
| $4.92M | 0.01% |
+458,217
| New | +$5.1M |
|
396
iShares Russell 2000 ETF
IWM
$80.2B
| $4.9M | 0.01% |
19,755
+13,160
| +200% | +$3.39M |
|
397
Hanmi Financial
HAFC
$940M
| $4.87M | 0.01% |
184,634
-6,737
| -4% | -$181K |
|
398
Colgate-Palmolive
CL
$73.3B
| $4.8M | 0.01% |
56,308
-14,226
| -20% | -$1.27M |
|
|
BGB
399
Blackstone Strategic Credit 2027 Term Fund
BGB
$499M
| $4.79M | 0.01% |
+429,518
| New | +$4.96M |
|
400
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $4.67M | 0.01% |
42,876
+1,981
| +5% | +$218K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2026 Portfolio in Review
As of Q1 2026, Loomis, Sayles & Company held 784 positions worth $74.3B, down 10% from $83B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Loomis, Sayles & Company's Q1 2026 filing shows 89 new, 180 increased, 401 reduced and 66 closed positions. Its largest new stake was PTC Therapeutics: 493,603 shares worth $33.6M. The largest sale was Illumina, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q1 2026 buy was PTC Therapeutics: 493,603 shares worth $33.6M.
- Loomis, Sayles & Company added most to Booking.com in Q1 2026, an estimated $556M increase.
- Loomis, Sayles & Company's biggest Q1 2026 reduction was Illumina, cutting an estimated $161M.
- Loomis, Sayles & Company fully exited Wave Life Sciences in Q1 2026, selling an estimated $34.7M.
- Loomis, Sayles & Company's ten largest holdings make up 52% of its $74.3B portfolio in Q1 2026.
- Loomis, Sayles & Company opened 89 new positions and closed 66 in Q1 2026.
- Loomis, Sayles & Company's portfolio value fell 10% quarter-over-quarter to $74.3B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.